Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Rallybio Corporation Common Stock stock

Learn how to easily invest in Rallybio Corporation Common Stock stock.

Rallybio Corporation Common Stock is a biotechnology business based in the US. Rallybio Corporation Common Stock shares (RLYB) are listed on the NASDAQ and all prices are listed in US Dollars. Rallybio Corporation Common Stock employs 31 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Rallybio Corporation Common Stock

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – RLYB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Rallybio Corporation Common Stock stock price (NASDAQ: RLYB)

Use our graph to track the performance of RLYB stocks over time.

Rallybio Corporation Common Stock shares at a glance

Information last updated 2022-01-20.
Latest market close$9.72
52-week range$8.06 - $25.78
50-day moving average $11.96
200-day moving average $14.12
Wall St. target price$30.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-5.11

Buy Rallybio Corporation Common Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Stocks
$0
0%
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$0
$1 per month
$5
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Public
Stocks, ETFs, Cryptocurrency
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Rallybio Corporation Common Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Rallybio Corporation Common Stock price performance over time

Historical closes compared with the close of $9.72 from 2022-01-20

1 week (2022-01-14) 9.58%
1 month (2021-12-21) -9.67%
3 months (2021-10-21) -39.14%
6 months (2021-07-17) N/A
1 year (2021-01-17) N/A
2 years (2020-01-17) N/A
3 years (2019-01-17) N/A
5 years (2017-01-17) N/A

Rallybio Corporation Common Stock financials

Gross profit TTM $0
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value $5.80
Market capitalisation $278.9 million

TTM: trailing 12 months

Rallybio Corporation Common Stock share dividends

We're not expecting Rallybio Corporation Common Stock to pay a dividend over the next 12 months.

You may also wish to consider:

Rallybio Corporation Common Stock overview

Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a preclinical-stage monoclonal anti-HPA-1a antibody for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT). The company is also developing RLYB211, a polyclonal anti-HPA-1a antibody that is in a Phase 1/2 clinical trial for the prevention of FNAIT; RLYB114, a pegylated C5 inhibitor in preclinical development for the treatment of complement-mediated ophthalmic diseases; and RLYB116, a subcutaneously administered inhibitor of complement factor 5, or C5, for the treatment of patients with paroxysmal nocturnal hemoglobinuria and generalized myasthenia gravis. The company also has discovery-stage programs that are focused on the identification of small molecule therapeutics for patients with rare metabolic diseases. Rallybio has collaboration with Exscientia for the development of small molecule therapeutics for rare diseases. Rallybio Corporation was incorporated in 2018 and is headquartered in New Haven, Connecticut. Rallybio Corporation operates as a subsidiary of Rallybio Holdings, LLC.

Frequently asked questions

What percentage of Rallybio Corporation Common Stock is owned by insiders or institutions?
Currently 7.431% of Rallybio Corporation Common Stock shares are held by insiders and 75.047% by institutions.
How many people work for Rallybio Corporation Common Stock?
Latest data suggests 31 work at Rallybio Corporation Common Stock.
When does the fiscal year end for Rallybio Corporation Common Stock?
Rallybio Corporation Common Stock's fiscal year ends in December.
Where is Rallybio Corporation Common Stock based?
Rallybio Corporation Common Stock's address is: 234 Church Street, New Haven, CT, United States, 06510
What is Rallybio Corporation Common Stock's ISIN number?
Rallybio Corporation Common Stock's international securities identification number is: US75120L1008

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site